Celecoxib versus placebo as an adjunct in the treatment of Adolescents with bipolar mood disorder.

Not Applicable

• Conditions: Bipolar affective disorder, current episode manic without psychotic symptoms; F31.1, F31; Bipolar disorder.

• Registration Number: IRCT2015080423478N1
• Lead Sponsor: Vice chancellor for research, Tehran University of Medical Sciences, DR Masud Younesian

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Bipolar disorder (first episode); acute illness episode; manic phase; and Young Mania Rating Scale score 20 or more; age 12 to 18 years
Exclusion criteria: Liver, kidney, heart and thyroid disorders at present; history of renal dysfunction or heart or a history of stomach ulcers; hypersensitivity to sulfonamides; co-morbidity risk of autism spectrum disorders; the risk of mental retardation; substance abuse over the past year; Mood Disorder caused by physical illness such as seizures; head trauma and other diseases

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bipolar disorder. Timepoint: Second week, Forth week, Week eight. Method of measurement: YMRS scale.

Secondary Outcome Measures

Name	Time	Method
Patient function. Timepoint: Before treatment and at week eight. Method of measurement: CGAS Scale.